Citi Unveils H-Shr Top Buys: Key Stocks Set for Growth

Share this story:

Citi Releases Latest Top Buy Recommendations for H Shares

AASTOCKS Financial News — In its latest research update, Citi has published its top buy recommendations for H shares, highlighting key companies with promising outlooks and target prices. The list gives investors insight into some of the leading Hong Kong-listed Chinese companies that Citi believes offer attractive investment opportunities.

Citi’s Top Buy Picks and Target Prices

The bank’s selected H share top buys along with their respective target prices (TPs) are as follows:

  • Tencent Holdings Limited (00700.HK)
    Current Price: HKD 9.40 (down 2.164%)
    Target Price: HKD 763

  • AIA Group Limited (01299.HK)
    Current Price: HKD 0.96 (down 1.154%)
    Target Price: HKD 103

  • Jiangsu Hengrui Medicine Co., Ltd. (01276.HK)
    Current Price: HKD 1.95 (down 3.242%)
    Target Price: HKD 134

  • MMG Limited (01208.HK)
    Current Price: HKD 0.26 (down 2.820%)
    Target Price: HKD 11.2

  • Trip.com Group Limited (TCOM.US)
    Target Price: USD 82

  • China International Capital Corporation Limited (CICC) (03908.HK)
    Current Price: HKD 0.77 (down 3.775%)
    Target Price: HKD 27.66

  • Montage Technology Group Limited (06809.HK)
    Current Price: HKD 10.20 (down 2.175%)
    Target Price: HKD 305

  • ASM Pacific Technology Limited (00522.HK)
    Current Price: HKD 4.10 (down 2.012%)
    Target Price: HKD 180

Additional Market Details

Citi’s report also notes significant short selling activity across these stocks as of May 28, 2026, with notable short selling ratios such as AIA at 26.182% and Hengrui Pharma at 28.088%. This information can provide investors with insight into market sentiment and potential risks.

Context and Implications

The selection of Tencent and AIA reaffirms Citi’s confidence in major players in technology and insurance sectors within the Hong Kong market, respectively. Meanwhile, picks like Hengrui Pharma underscore attention to the healthcare industry, reflecting ongoing interest in pharmaceutical innovation and growth potential.

The inclusion of companies such as MMG, a mining firm, and Trip.com, a leading travel service provider, shows Citi’s diversified approach, spanning sectors from commodities to consumer services.

Investor Action

This list serves as a strategic guide for investors focusing on H shares, showcasing where Citi sees value and growth potential. Market participants should consider these recommendations alongside their own due diligence and investment goals.

Disclaimer

Stock prices quoted are delayed by at least 15 minutes. Short selling data is as of May 28, 2026, 16:25 HKT. Investors are advised to refer to original research releases and consult financial advisors before making investment decisions.


For detailed market updates, analysis, and comprehensive financial news, visit AASTOCKS Financial News.

Related Topics: Hong Kong Stocks, H Shares, Citi Research, Investment Recommendations, Market Analysis

Share this story:

Leave a Reply

Your email address will not be published. Required fields are marked *